featured

Drop in biological initiation for patients with psoriasis during the COVID‐pandemic

EPI-PHARE members sign a research letter in British Journal of Dermatology: Drop in biological initiation...

featured

Reports 03/08/2021

Stents and balloons used in obliterative arterial disease of the lower limbs in France...

A study from data of the SNDS

featured

Reports 02/05/2021

Pharmaco-epidemiological surveillance of COVID-19 vaccines

Frequency of deaths and hospitalizations in 2018 and 2019 among non-institutionalized people aged 65 and...

featured

Publications 02/04/2021

Use of high dose cyproterone acetate and risk of intracranial meningioma in women

EPI-PHARE members co-sign an article in BMJ : Use of high dose cyproterone acetate and risk of...

Publications 01/27/2021

Drug use for gastrointestinal symptoms during pregnancy

EPI-PHARE members cosign an article in PlosOne : Drug use for gastrointestinal symptoms during pregnancy:...

Reports 01/21/2021

Pharmaco-epidemiological surveillance of COVID-19 vaccines

Frequency of deaths and hospitalizations among people living in EHPAD or long-term care unit (USLD) in...

Publications 01/11/2021

Antihypertensive Drugs and COVID-19 Risk

Members of EPI-PHARE sign an article in Hypertension: Antihypertensive Drugs and COVID-19 Risk: A Cohort...

Publications 01/07/2021

Colonoscopy in France during the COVID-19 pandemic

Members of EPI-PHARE sign a Research Letter in International Journal of Colorectal Disease: Colonoscopy...

Publications 12/18/2020

Anti-VEGF use in France during the Covid-19 pandemic

Members of EPI-PHARE sign a Research Letter in Jama Ophthalmology: Intravitreal Anti–Vascular...

Reports 12/16/2020

Drug use in France during the Covid-19 pandemic

Report 5: Update until November 22, 2020

Publications 10/23/2020

Antiepileptic drugs and risk of early neurodevelopmental disorders

Members of EPI-PHARE cosign an article in Scientific Reports : Risk of early neurodevelopmental disorders...

Reports 10/09/2020

Drug use in France during the Covid-19 pandemic

Report 4: Update until September 13, 2020

Publications 09/16/2020

Pregnancy and inflammatory bowel disease

Members of EPI-PHARE cosign an article in Alimentary Pharmacology & Therapeutics : Pregnancy in women...

Publications 07/27/2020

Breast cancer chemotherapy and risk of secondary hematologic cancers

Members of EPI-PHARE cosign an article in International Journal of Cancer : Risk of secondary hematologic...

Publications 07/16/2020

Oral anticoagulants and risk of acute liver injury

Members of EPI-PHARE cosign an article in Scientific Reports : Oral anticoagulants and risk of acute liver...

Reports 06/12/2020

Drug use in France during the Covid-19 pandemic

Report 3: Update after the end of the confinement

Publications 06/10/2020

Antiepileptic drugs during pregnancy and neurodevelopmental outcomes

EPI-PHARE members cosign an article in BMJ Open: Risk of early neurodevelopmental outcomes associated with...

Reports 05/04/2020

Drug use in France during the Covid-19 pandemic

Report 2: Update after five weeks of confinement (until April 19, 2020)

Reports 04/21/2020

Drug use in France during the Covid-19 pandemic

Report 1: Update on the first two weeks of confinement

Reports 02/10/2020

Exposure to Mycophenolic Acid Products during pregnancy from 2010 to 2017 in France

A Nationwide Cohort Study from SNDS data.

Reports 12/01/2019

Follow-up of the use of Truvada® or generics for pre-exposure prophylaxis (PrEP) for HIV

Study from SNDS data.

Reports 06/13/2019

Impact of Levothyrox formulation change on health and healthcare use in France

A pharmaco-epidemiology study in real life from the SNDS data.

Reports 12/19/2018

Use of proton pump inhibitors in adults in France: a nationwide drug utilization study

Observational study from the SNDS data, 2015.